Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study.
Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study.
复制标题
DOI:
10.1136/thx.2009.126052
复制
发表时间:
2010-06
期刊:
影响因子:
10
通讯作者:
Martinez FD
中科院分区:
文献类型:
--
作者:
Guerra S;Sherrill DL;Venker C;Ceccato CM;Halonen M;Martinez FD
Recent studies have suggested that a restrictive pattern assessed with a single spirometry is associated with increased morbidity and mortality. In this study, we sought to determine demographic, clinical, and mortality profiles of subjects with either a recurrent or inconsistent restrictive spirometric pattern assessed prospectively. We analyzed data from 2048 adult participants in the population-based TESAOD study. Normal (FEV1/FVC ratio≥70% and FVC≥80% predicted), restrictive (FEV1/FVC≥70% and FVC<80% predicted), and obstructive (FEV1/FVC<70%) patterns were assessed at the enrollment survey (1972) and in eleven subsequent follow-up surveys up to 1996. Demographic and clinical characteristics were measured at enrollment and vital status and cause of death were assessed as of January 2005. Overall, 12% of participants had a restrictive spirometric pattern at enrollment. They were less likely to be males, to smoke and to have asthma, and had lower IgE levels as compared with subjects in the obstructive group. Among subjects with a restrictive pattern at enrollment, 38% developed an obstructive pattern during the follow-up. The remaining 62% had either a recurrent (restrictive pattern≥50% of follow-up surveys) or inconsistent (restrictive pattern<50% of follow-up surveys) longitudinal restrictive pattern. The recurrent and inconsistent restrictive groups had increased mortality risk for all-cause (adjHR: 1.7, 1.3–2.3; and 1.9, 1.4–2.6; respectively), heart disease (2.0, 1.3–3.1; and 2.7, 1.7–4.3), stroke (2.4, 0.9–6.3; and 3.5, 1.2–9.8), and diabetes (8.0, 2.9–21.8; and 6.0, 1.9–19.2). The restrictive spirometric pattern identifies a pulmonary condition that is distinguishable from obstructive lung disease and associated with increased risk of life-threatening co-morbidities.
登录
查看更多内容
影响因子:
24.3
作者:
Mannino, D. M.;Thorn, D.;Holguin, F.
通讯作者:
Holguin, F.
影响因子:
120.7
作者:
Jemal, A;Ward, E;Thun, M
通讯作者:
Thun, M
影响因子:
5
作者:
LEBOWITZ, MD;KNUDSON, RJ;BURROWS, B
通讯作者:
BURROWS, B
影响因子:
39.2
作者:
ASHLEY, F;KANNEL, WB;MASSON, R
通讯作者:
MASSON, R
DOI:
10.1164/arrd.1983.128.3.501
发表时间:
1983-01-01
期刊:
AMERICAN REVIEW OF RESPIRATORY DISEASE
影响因子:
--
作者:
RAY, CS;SUE, DY;WASSERMAN, K
通讯作者:
WASSERMAN, K